Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease

We evaluated the ability of vedolizumab to induce endoscopic and histologic remission in patients with Crohn's disease (CD). We performed a prospective study of 110 patients with active CD, based on CD activity index (CDAI) scores >220 and mucosal ulcerations, who received open-label vedoliz...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2019-10, Vol.157 (4), p.997-1006.e6
Hauptverfasser:	Löwenberg, Mark, Vermeire, Severine, Mostafavi, Nahid, Hoentjen, Frank, Franchimont, Denis, Bossuyt, Peter, Hindryckx, Pieter, Rispens, Theo, de Vries, Annick, van der Woude, C. Janneke, Berends, Sophie, Ambarus, Carmen A., Mathot, Ron, Clasquin, Esme, Baert, Filip, D’Haens, Geert
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-integrin α Biologic IBD LOVE-CD Trial
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!